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Highly pathogenic avian H5N1 influ-
enza viruses are now enzootic in parts of
Southeast Asia and the Middle East.
Occasionally, these viruses transmit to
humans and cause severe respiratory
disease and fatalities. Currently, these
viruses are not efficiently transmitted from
person to person, although limited human-
to-human transmission may have occurred
[1–4]. A major determinant of influenza
virus host range is the viral hemagglutinin
(HA) protein: avian virus HA binds
preferentially to sialic acid linked to the
penultimate galactose residue by an a2,3-
linkage (Siaa2,3Gal) [5–7], as found for
sialic acid–containing receptors of the
epithelial cells in duck intestine [8], the
site of avian influenza virus replication. By
contrast, human virus HA has higher
affinity for Siaa2,6Gal [5–7], the main
sialyloligosaccharide on the epithelial cells
of the human upper respiratory tract
[9,10].
Recently, Herfst et al. [11] and Imai
et al. [12] identified H5 HA-possessing
viruses that transmit via respiratory drop-
lets among ferrets, an established animal
model for influenza virus transmission
studies. The H5N1 transmissible virus
identified by Herfst et al. [11] possesses
three mutations that were intentionally
introduced (PB2-627K, which confers
efficient replication in mammals [13],
and HA-Q222L/G224S (H5 numbering),
which confer human-type receptor-bind-
ing specificity [14,15]). The ‘‘Herfst virus’’
also possessed two mutations that emerged
during virus passages in ferrets. One of
these, HA-T156A, results in the loss of a
glycosylation site on the head of the HA;
the other, HA-H103Y, localizes to the HA
trimer interface. The transmissible virus
identified by Imai et al. [12] possesses a
mutant HA gene of an avian H5N1 virus
and the remaining seven viral genes of a
prototypic pandemic 2009 (H1N1) virus.
Random mutagenesis of the HA globular
head identified two mutations in HA (HA-
N220K and HA-Q222L; note that the
latter is identical to one of the mutations
identified in the ‘‘Herfst virus’’) that
conferred human-type receptor-binding
specificity. Virus passages in ferrets result-
ed in the selection of two additional
mutations in HA. One of these, HA-
N154D, resulted in the loss of the same
glycosylation site as HA-T156A in the
‘‘Herfst virus’’; the other, T314I, affected
HA stability [12]).
Although the Herfst and Imai studies
used different experimental strategies and
tested viruses of HA/H5 clade 2 or 1,
respectively, the results were remarkably
similar: the transmissible mutant H5
viruses bound to human-type receptors,
lost the glycosylation site at HA-154–156,
and acquired an additional mutation in
HA that likely increased the protein’s
stability. Moreover, both studies, and
findings by others [16–18], suggest that a
shift towards human-type receptor-bind-
ing specificity may be necessary, but not
sufficient, for H5N1 virus transmissibility
in mammals.
The loss of a glycosylation site at HA-
154–156, using two different mutations, is
particularly notable. Amino acids 154–156
of many H5 HAs encode an N-glycosyla-
tion site (N-X(except P)-S/T), which is
located near the receptor-binding pocket.
Loss of this glycosylation site enhances
H5N1 virus binding to Siaa2,6Gal (con-
ferred by the Q226L/G228 mutations
[19]) and is critical for H5N1 virus
transmissibility in guinea pigs [20]. In the
Herfst and Imai studies, loss of this
glycosylation site occurred during the first
virus passages in ferrets, suggesting that
this trait is essential for H5 virus transmis-
sibility in ferrets.
Since lack of the HA154–156 glycosyl-
ation site appears to be critical for H5
virus transmission in mammals, we in-
spected avian H5N1 viruses for this
feature. A phylogenetic tree of publicly
available H5 HA sequences showed that a
substantial number of these viruses, dis-
tributed across time and geography, lack
this glycosylation site. Closer inspection of
2009–2011 H5N1 viruses from Vietnam,
Indonesia, and Egypt (i.e., countries with
appreciable numbers of human H5N1
infections) revealed that ,25% of Viet-
namese, 0% of Indonesian, but .70% of
Egyptian isolates lack the HA154–156
glycosylation site. The H5N1 viruses
currently circulating in Egypt are descen-
dants of the so-called Qinghai Lake viruses
that killed wild birds (which typically do
not succumb to influenza virus infections)
at Qinghai Lake, China, in 2005 [21–23],
and have now spread through Europe to
the Middle East and Africa.
Next, we looked for a correlation
between the HA154–156 glycosylation site
and recent human H5N1 virus infections.
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Human H5N1 infections in Vietnam and
Indonesia from 2009 to 2011 were mostly
(Vietnam) or exclusively (Indonesia) caused
by viruses with the HA154–156 glycosyla-
tion site. However, all 46 H5N1 viruses
isolated in 2009–2011 from infected indi-
viduals in Egypt lacked the HA154–156
glycosylation site, while 28% of H5N1
viruses circulating in avian species in Egypt
in 2009–2011 possessed this site (Table 1).
Phylogenetic analysis further suggested that
mutations resulting in loss of the glycosyl-
ation site occurred in birds and that these
variants subsequently transmitted to hu-
mans. Although speculative at this point,
this finding might suggest that avian H5N1
viruses lacking the HA154–156 glycosyla-
tion site transmit to humans more readily
than those that possess the glycosylation
site, at least in the genetic background of
Egyptian H5N1 viruses.
In addition to mutations in HA, other
amino acid changes may be critical to
confer transmissibility in humans. One
such mutation may be the glutamic acid-
to-lysine mutation at position 627 of the
PB2 polymerase protein (PB2-627K),
which confers efficient replication in
mammals [13] and is a recognized host
determinant of influenza viruses [24].
Herfst introduced this mutation into their
virus; the ‘‘Imai virus’’ possesses the 2009
pandemic PB2 gene, in which a basic
amino acid at position 591 compensates
for the lack of PB2-627K [25,26]. The
mammalian-adapting PB2-627K mutation
also emerged in the Qinghai Lake viruses
[21–23] and has been maintained in
viruses of this lineage to this day, with
the exception of a few revertants. Most
Egyptian H5N1 viruses, which descend
from the Qinghai Lake viruses, thus
possess two mutations that may facilitate
transmissibility in mammals: a mutation in
HA (resulting in the lack of a glycosylation
site) that is critical for H5N1 virus
transmissibility in ferrets and guinea pigs,
and a mutation in PB2 that confers
efficient replication in mammals. In addi-
tion, some Egyptian H5N1 viruses have
acquired increased affinity for human-type
receptors [27].
The data presented here are invaluable
for monitoring circulating viruses for vari-
ants with increased potential to acquire
transmissibility to mammals. Our database
searches identified two H5N1 viruses that
encode HA-220K and have lost the
HA154–156 glycosylation site (A/muscovy
duck/Vietnam/NCVD-11/2007; A/
duck/Egypt/10185SS/2010), indicating
that only two additional mutations are
needed to create variants with the ‘‘trans-
missibility features’’ identified in the Ka-
waoka study. Because the outbreak of
H5N1 viruses in Egypt is extensive, Egyp-
tian H5N1 viruses may, therefore, present a
far greater pandemic risk than H5N1
viruses circulating in other countries.
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